As the US Food and Drug Administration (FDA) is about to issueCosmetics & Personal Carethe final guidelines for factory registration and product listing, the industrys attention continues to rise. The following is a summary of the latest progress:

FDA已于2023年8月放出了化妝品工廠(chǎng)注冊(cè)和產(chǎn)品列名的指南草案，至今已吸引超過(guò)40條意見(jiàn)和建議。這些反饋涵蓋了多方面的關(guān)注點(diǎn)，F(xiàn)DA正對(duì)這些建議進(jìn)行評(píng)估，并將基于此發(fā)布最終指南。最終的發(fā)布意味著企業(yè)將獲得更明確的方向，以便完成工廠(chǎng)注冊(cè)和產(chǎn)品列名的要求。

In October this year, the FDA introduced the Structured Product Labeling (SPL) guidelines related to cosmetics. The use of SPL documents makes the information more standardized, facilitating the automatic processing of the FDAs database, and thus enabling timely and efficient updates of factory registration and product listing. The FDA has confirmed that in the near future, a new reporting system will be launched, and the specific start date will be announced in the next few weeks.

Enterprises should closely follow the updates regarding the launch of the electronic platform or the templates for submitting paper materials (Forms FDA 5066 and 5067). Although the FDA does not require the upload of SPL documents in the electronic system, and enterprises can also directly fill in the relevant information online, the standardized SPL documents are still the recommended option. For the traditional mode, the FDA still accepts the submission of paper materials.